HeartSciences Inc. (HSCS)

Market Cap	15.26M +38.9%
Revenue (ttm)	4,519 -27.7%
Net Income	-10.26M
EPS	-3.19
Shares Out	4.80M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,804
Open	2.950
Previous Close	3.020
Day's Range	2.890 - 3.239
52-Week Range	1.630 - 5.250
Beta	1.78
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 14, 2026

About HSCS

HeartSciences Inc., a medical technology company, focuses on advancing electrocardiography (ECG) through the integration of artificial intelligence. It develops artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction, as well as conventional ECG information in the same test; and MyoVista Insights, a cloud-native vendor- and device-agnostic EC...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Jun 15, 2022
• Employees: 14
• Stock Exchange: Nasdaq
• Ticker Symbol: HSCS
• Website: https://heartsciences.com

Financial Performance

In fiscal year 2026, HeartSciences's revenue was $4,319, a decrease of -0.71% compared to the previous year's $4,350. Losses were -$9.14 million, 4.30% more than in 2025.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 16, 2026

Data Sources Report a data error